2 results
Approved WMOCompleted
The objective of this project is to assess the applicability of [18F]PK209 for in vivo imaging of the NMDA receptor.
Approved WMOCompleted
The primary objective of the main non-inferiority study is to determine the safety of TACmono starting nine months after kidney transplantation in immunologically low-risk patients in terms of BPAR-rate 15 months after transplantation compared to…